Endometrial Dedifferentiated Carcinoma
4 clinical trials · Condition
◉ Watch Endometrial Dedifferentiated Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma (NCT05112601) | National Cancer Institute (NCI) | 2022-06-02 |
| Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer (NCT03914612) | National Cancer Institute (NCI) | 2019-08-22 |
| Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers (NCT05049538) | M.D. Anderson Cancer Center | 2019-06-18 |
Track Endometrial Dedifferentiated Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.